SecBot SecBot
SECBOTREPLAY Home › Report › GSK

GSK · GSK announced the appointment of Roy Jakobs, CEO of Royal Philips, as…

GSK plc · 6-K filed Jul 9, 2026 at 07:27 ET

At the news

NEUTRALIMPACT 2/10

6-K filed Jul 9, 2026 at 07:27 ET

GSK announced the appointment of Roy Jakobs, CEO of Royal Philips, as an independent Non-Executive Director effective July 13, 2026. This is a routine board addition bringing health technology expertise, with no material financial impact or strategic change.

  • Roy Jakobs to join GSK board as independent Non-Executive Director from July 13, 2026
  • Jakobs is currently CEO of Royal Philips (EUR 17.8B sales in 2025, 65,000 employees)
  • Standard annual fee of £122,258 for the non-executive role
  • Board expands to 13 members as of the effective date

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access